Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells

Cancer Research

Volumn 60, Issue 22, 2000, Pages 6391-6395

  Kikuchi, T ^a   Miyazawa, N ^a   Moore, M A S ^a   Crystal, R G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN GP 39; VIRUS VECTOR;

ADENOVIRUS; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA MODIFICATION; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TUMOR REGRESSION;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELL DIVISION; COLONIC NEOPLASMS; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GENE THERAPY; GENETIC VECTORS; IMMUNOTHERAPY, ADOPTIVE; INJECTIONS, INTRALESIONAL; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033677284     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. CD40 and CD154 in cell-mediated immunity
2. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells
3. Dendritic cells and the control of immunity
4. Activation of human dendritic cells through CD40 cross-linking
5. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
6. High level IL- production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
7. CD4 T cells and their role in antitumor immune responses
8. Help for cytotoxic-T-cell responses is mediated by CD40 signalling
9. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
10. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
11. Anti-tumor immunity induced by in vivo adenovirus vector-mediatd expression of CD40 ligand in tumor cells
12. Biological behavior of malignant melanoma cells correlated to their survival in vivo
13. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen
14. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
15. Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1A is immunodominant in H-2b, but not in H-2d or H-2k mice
16. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
17. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector
18. Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo
19. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium
20. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
21. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
22. Interleukin 2
23. Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors